TIDMKMK
RNS Number : 0223O
Kromek Group PLC
28 September 2023
28 September 2023
Kromek Group plc
("Kromek" or the "Group")
Result of AGM
Kromek Group plc, a leading developer of radiation and
bio-detection technology solutions for the advanced imaging and
CBRN detection segments, announces that at its Annual General
Meeting ("AGM"), held earlier today, all resolutions were duly
passed.
Details of the proxy voting results, which should be read
alongside the Notice of AGM, are below:
Resolution Votes for Votes against Votes Total
withheld proxy votes
No. of % of votes No. of % of votes No. of
votes cast* votes cast* votes
------------ ----------- ----------- ----------- ---------- -------------
1 189,476,538 94.43 11,176,883 5.57 217,336 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
2 179,826,325 90.14 19,674,285 9.86 1,370,147 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
3 182,008,714 91.33 17,274,285 8.67 1,587,758 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
4 198,554,316 99.71 582,433 0.29 1,734,008 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
5 199,638,889 99.60 806,687 0.40 425,181 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
6 198,643,359 98.98 2,051,977 1.02 175,421 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
7 191,067,728 96.32 7,295,934 3.68 2,507,095 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
8 187,184,965 93.34 13,353,050 6.66 332,742 200,870,757
------------ ----------- ----------- ----------- ---------- -------------
*Excludes withheld votes
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
Cavendish Capital Markets Limited (Nominated
Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker -
Corporate Finance
Tim Redfern/Charlotte Sutcliffe - ECM +44 (0)20 7220 0500
Michael Johnson/Tamar Cranford-Smith - Sales
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury/Henry Gamble +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation and solid-state readout
technology, are primarily used to protect critical infrastructure,
events, personnel and urban environments from the threat of 'dirty
bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGEAENPAADDEFA
(END) Dow Jones Newswires
September 28, 2023 06:25 ET (10:25 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Dec 2024 to Jan 2025
Kromek (LSE:KMK)
Historical Stock Chart
From Jan 2024 to Jan 2025
